BioSpace News Archive

Health Canada would like to remind Canadians to protect themselves and their families from the sun.

June 1, 2018 marks the 15th anniversary for Camargo Pharmaceutical Services, LLC, (“Camargo”).

GlycoMimetics, Inc. announced that Chief Executive Officer Rachel King will provide a company overview at the Jefferies Annual Health Care Conference.

BD (Becton, Dickinson and Company) announced that it will present at the several upcoming investor healthcare conferences.

Asymchem announced that its Fuxin 1 site, a dedicated carbapenem manufacturing facility, successfully passed the U.S. Food and Drug Administration (USFDA) general GMP reinspection conducted between March 12-15, 2018.

The Janssen Pharmaceutical Companies of Johnson & Johnson announced results from a pre-planned interim analysis of the Phase 3 iNNOVATE (PCYC-1127) study evaluating the investigational use of IMBRUVICA® (ibrutinib) in combination with rituximab in relapsed/refractory and treatment-naïve patients with Waldenström’s macroglobulinemia (WM).

Mylan N.V. and Biocon Ltd. announced that 48-week results from the HERITAGE study will be presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting.

Paralyzed Veterans of America today announced that David Zurfluh, an Air Force veteran, and native of Washington state, will serve as national president for a 2nd consecutive term.

Bristol-Myers Squibb Company announced that the U.S. Food and Drug Administration (FDA) lifted a partial clinical hold placed on CA209-602 (CheckMate -602).

NOBLES MEDICAL TECHNOLOGIES II, INC. announced it has officially launched sales in the Netherlands with its first Dutch center performing several successful PFO closure cases at the University Medical Center in Utrecht, Netherlands.